Warning! GuruFocus detected
6 Severe warning signs
with GDS.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Ramsay Generale de Sante SA
ISIN : FR0000044471
Compare
Compare
Traded in other countries / regions
GDS.FranceGD6.Germany0OD6.UK IPO Date
2001-06-19Description
Ramsay Generale de Sante SA operates in the private healthcare sector in France. The company provides a comprehensive range of patient care services in thirteen business segments: Nouvelle Aquitaine, Bourgogne-Franche Comte, Brittany, Centre-Val de Loire, Hauts de France, Normandy, Provence Alpes Cote d'Azur, Ile de France, Auvergne-Rhone Alpes, Occitanie, Italy, Nordics, and Head Office. It generates maximum revenue from the Ile de France segment. The company also specializes in cardiology, heart surgery, digestive surgery, dermatology, urology, ophthalmology, vascular and endovascular surgery.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.05 | |||||
| Equity-to-Asset | 0.17 | |||||
| Debt-to-Equity | 3.5 | |||||
| Debt-to-EBITDA | 6.82 | |||||
| Interest Coverage | 0.83 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 0.87 | |||||
| Beneish M-Score | -2.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.6 | |||||
| 3-Year EBITDA Growth Rate | -1.4 | |||||
| 3-Year FCF Growth Rate | -4.2 | |||||
| 3-Year Book Growth Rate | 3.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.02 | |||||
| 9-Day RSI | 41.8 | |||||
| 14-Day RSI | 44.62 | |||||
| 3-1 Month Momentum % | -16.41 | |||||
| 6-1 Month Momentum % | -20.45 | |||||
| 12-1 Month Momentum % | -21.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.81 | |||||
| Quick Ratio | 0.72 | |||||
| Cash Ratio | 0.13 | |||||
| Days Inventory | 40.68 | |||||
| Days Sales Outstanding | 40.92 | |||||
| Days Payable | 146.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 12.54 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 78.33 | |||||
| Operating Margin % | 3.36 | |||||
| Net Margin % | -1.55 | |||||
| FCF Margin % | 8.55 | |||||
| ROE % | -6.72 | |||||
| ROA % | -1.18 | |||||
| ROIC % | 2.44 | |||||
| 3-Year ROIIC % | -9.59 | |||||
| ROC (Joel Greenblatt) % | 4.75 | |||||
| ROCE % | 2.66 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 26.61 | |||||
| Price-to-Owner-Earnings | 5.81 | |||||
| PS Ratio | 0.23 | |||||
| PB Ratio | 1.02 | |||||
| Price-to-Free-Cash-Flow | 2.64 | |||||
| Price-to-Operating-Cash-Flow | 1.91 | |||||
| EV-to-EBIT | 35.41 | |||||
| EV-to-EBITDA | 8.52 | |||||
| EV-to-Revenue | 0.96 | |||||
| EV-to-FCF | 11.25 | |||||
| Price-to-GF-Value | 0.42 | |||||
| Price-to-Projected-FCF | 0.24 | |||||
| Price-to-Median-PS-Value | 0.44 | |||||
| Earnings Yield (Greenblatt) % | 2.82 | |||||
| FCF Yield % | 39.1 | |||||
| Forward Rate of Return (Yacktman) % | 37.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Ramsay Generale de Sante SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 5,143.6 | ||
| EPS (TTM) (€) | -0.72 | ||
| Beta | 0.03 | ||
| 3-Year Sharpe Ratio | -0.86 | ||
| 3-Year Sortino Ratio | -1.04 | ||
| Volatility % | 35.26 | ||
| 14-Day RSI | 44.62 | ||
| 14-Day ATR (€) | 0.170703 | ||
| 20-Day SMA (€) | 10.3375 | ||
| 12-1 Month Momentum % | -21.03 | ||
| 52-Week Range (€) | 9.54 - 16.9 | ||
| Shares Outstanding (Mil) | 110.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ramsay Generale de Sante SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ramsay Generale de Sante SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ramsay Generale de Sante SA Frequently Asked Questions
What is Ramsay Generale de Sante SA(XPAR:GDS)'s stock price today?
The current price of XPAR:GDS is €10.20. The 52 week high of XPAR:GDS is €16.90 and 52 week low is €9.54.
When is next earnings date of Ramsay Generale de Sante SA(XPAR:GDS)?
The next earnings date of Ramsay Generale de Sante SA(XPAR:GDS) is .
Does Ramsay Generale de Sante SA(XPAR:GDS) pay dividends? If so, how much?
Ramsay Generale de Sante SA(XPAR:GDS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers